|
    CEMI U.S.: Nasdaq

    Chembio Diagnostics Inc.

    CEMIUS
    After Hours
    Back To Top
    Last Updated: Jul 23, 2021 7:59 p.m. EDT Delayed quote

    $ 3.0000

    -0.06 -1.96%
    After Hours Volume: 589.01K
    Close Chg Chg %
    $3.0600 -1.2500 -29.00%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 24.04M 65 Day Avg: 9.26M
    260% vs Avg
    2.9500 Day Range 4.0600
    2.0600 52 Week Range 8.7500

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    CEMI Overview

    Key Data

    • Open $4.0000
    • Day Range 2.9500 - 4.0600
    • 52 Week Range 2.0600 - 8.7500
    • Market Cap $62.11M
    • Shares Outstanding 20.3M
    • Public Float 18.58M
    • Beta 0.44
    • Rev. per Employee $91.47K
    • P/E Ratio N/A
    • EPS -$1.2687
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 1.39M 06/30/21
    • % of Float Shorted 7.49%
    • Average Volume 9.26M

    Performance

    5 Day
    • 26.97%
    1 Month
    • -2.86%
    3 Month
    • -19.69%
    YTD
    • -35.58%
    1 Year
    • -39.64%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 3 Full Ratings

    Recent News

    • MarketWatch
    • Dow Jones

    Chembio Diagnostics Shares Rise 15% After Purchase Order for HIV Tests

    Chembio Diagnostics Shares Drop 14% After Doubling Wednesday

    Chembio Diagnostics Shares Triple After $28.3M Purchase Order

    Chembio Diagnostics Shares Jump Premarket on $28.3M Order

    Chembio's stock more than doubles off 11-year low after large order for COVID-19 antigen tests

    Chembio Diagnostics stock rockets on record volume after commercial launch of rapid COVID-19 test

    Read full story

    28 Investment Ideas From Barron’s Roundtable Experts to Beat the Market This Year

    Read full story

    Fauci suggests Johnson & Johnson COVID-19 vaccine could win emergency-use authorization in just two weeks

    Read full story

    U.K. doctors seek review of 12-week gap between vaccine doses

    Read full story

    Laboratory Corp. of America Holdings stock outperforms competitors on strong trading day

    Read full story

    West Pharmaceutical Services Inc. stock rises Friday, outperforms market

    Read full story

    Alexion Pharmaceuticals Inc. stock outperforms market on strong trading day

    Read full story

    Catalyst Pharmaceuticals Inc. stock underperforms Friday when compared to competitors

    Read full story

    Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading day

    Read full story

    Quest Diagnostics Inc. stock falls Friday, underperforms market

    Read full story

    Corbus Pharmaceuticals Holdings Inc. stock falls Friday, underperforms market

    Read full story

    Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors

    Read full story

    Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market

    Chembio's shares decline after FDA revokes authorization for its COVID-19 antibody test

    Chembio Diagnostics started at buy with $9 stock price target at Canaccord Genuity

    • Other News
    • Press Releases

    Covid-19 Test Innovations Drawing New Interest from FDA and Consortiums

    on Baystreet.ca

    Chembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen Tests from Brazil

    on TipRanks.com

    Colliers Securities Thinks Chembio Diagnostics’ Stock is Going to Recover

    on TipRanks.com

    Colliers Securities Reiterates Their Buy Rating on Chembio Diagnostics (CEMI)

    on SmarterAnalyst

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning

    on InvestorPlace.com

    CEMI Stock: One Huge Reason Chembio Is Rocketing Higher Today

    on InvestorPlace.com

    Colliers Securities Thinks Chembio Diagnostics’ Stock is Going to Recover

    on SmarterAnalyst

    Today’s Biggest Pre-Market Movers: 10 Top Stock Gainers and Losers on Monday Morning

    on InvestorPlace.com

    Analysts Offer Insights on Healthcare Companies: and Chembio Diagnostics (CEMI)

    on SmarterAnalyst

    Analysts Offer Insights on Healthcare Companies: Chembio Diagnostics (CEMI) and Ontrak (OTRK)

    on SmarterAnalyst

    Testing Demand Will Increase as Pandemic Worsens

    on Baystreet.ca

    Demand for Pandemic Testing Could Rise Substantially with New Strain of Virus

    on Baystreet.ca

    6 Health Care Stocks Trading With Low Price-Sales Ratios

    on GuruFocus.com

    Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock?

    on Zacks.com

    Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% Higher

    on Zacks.com

    Implied Volatility Surging for Chembio (CEMI) Stock Options

    on Zacks.com

    Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock?

    on Zacks.com

    Implied Volatility Surging for Chembio Diagnostics (CEMI) Stock Options

    on Zacks.com

    Chembio Diagnostics (CEMI) Surges: Stock Moves 12.1% Higher

    on Zacks.com

    Implied Volatility Surging for Chembio Diagnostics (CEMI) Stock Options

    on Zacks.com

    Chembio Diagnostics Inc.

    Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases; handheld analyzers; and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Hauppauge, NY.

    Competitors

    Name Chg % Market Cap
    Response Genetics Inc. 3.23%
    OraSure Technologies Inc. 0.27% $811.71M
    Bio-Rad Laboratories Inc. Cl A 1.11% $20.39B
    Trinity Biotech PLC ADR -2.44% $41.8M
    Quidel Corp. 0.46% $6.39B
    Riot Blockchain Inc. -2.67% $2.7B
    Competitor Data Provided ByCapital Cube Logo